What is the address of J-C MAROT - médecine interne?

The registered office of J-C MAROT - médecine interne is located at Rue Marcel Lecomte(NR) 184, 5000 Namur.

Is J-C MAROT - médecine interne still active?

Yes. According to the CBE (3 October 2026) J-C MAROT - médecine interne is active, legal situation “Normale toestand”, started on 25 September 2006.

Is J-C MAROT - médecine interne registered on Peppol?

Yes, J-C MAROT - médecine interne is registered on the Peppol network with ID 0208:0883904382.

What is the enterprise number of J-C MAROT - médecine interne?

The enterprise number of J-C MAROT - médecine interne is BE0883904382.

When was J-C MAROT - médecine interne founded?

J-C MAROT - médecine interne was founded on 25 September 2006.

Who are the directors of J-C MAROT - médecine interne?

According to the 2025 annual accounts, the directors of J-C MAROT - médecine interne are: Jean Christophe MAROT.

Is J-C MAROT - médecine interne a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 September 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did J-C MAROT - médecine interne make in 2025?

J-C MAROT - médecine interne posted a profit after taxes of € 99,718 in financial year 2025.

What is the revenue of J-C MAROT - médecine interne?

As a small company, J-C MAROT - médecine interne is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 147,733.

J-C MAROT - médecine interne (Private Limited) - Namur

Dossier J-C MAROT - médecine interne, printed on 3 October 2026 from databakkes.be/en/0883904382/j-c-marot-medecine-interne. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

J-C MAROT - médecine interne from Namur, company number BE0883904382, closed financial year 2025 with a result of € 99,718 after tax. For that financial year J-C MAROT - médecine interne recorded a gross margin of € 147,733 and equity of € 67,700. Compared with financial year 2024, the result moved from € 98,569 to € 99,718. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 4, 2026.

What it is worth Growing

€ 67,700

▲ 43% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 99,718

▲ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 105,798

▲ 28% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 79,394 paid out

80 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 7,292

▼ 64% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 44,382

▼ 4% vs 2024

€ 38,480 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 342

▼ 85% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 35,953

▲ 24% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 5,622 Gross margin 2022: € 5,622 First fiscal year in the series	€ 71,000 Gross margin 2023: € 71,000 ▲ € 65,379 vs 2022 (€ 5,622) Favourable step	€ 150,668 Gross margin 2024: € 150,668 ▲ 112% vs 2023 (€ 71,000) Favourable step	€ 147,733 Gross margin 2025: € 147,733 ▼ 2% vs 2024 (€ 150,668) Unfavourable step	▼ 2%
Profit after taxes	€ -5,556 Profit after taxes 2022: € -5,556 First fiscal year in the series	€ 37,791 Profit after taxes 2023: € 37,791 ▲ € 43,348 vs 2022 (€ -5,556) Favourable step	€ 98,569 Profit after taxes 2024: € 98,569 ▲ 161% vs 2023 (€ 37,791) Favourable step	€ 99,718 Profit after taxes 2025: € 99,718 ▲ 1% vs 2024 (€ 98,569) Favourable step	▲ 1%
Equity	€ 42,017 Equity 2022: € 42,017 First fiscal year in the series	€ 42,808 Equity 2023: € 42,808 ▲ 2% vs 2022 (€ 42,017) Favourable step	€ 47,377 Equity 2024: € 47,377 ▲ 11% vs 2023 (€ 42,808) Favourable step	€ 67,700 Equity 2025: € 67,700 ▲ 43% vs 2024 (€ 47,377) Favourable step	▲ 43%
Total debts	€ 73,307 Total debts 2022: € 73,307 First fiscal year in the series	€ 115,801 Total debts 2023: € 115,801 ▲ 58% vs 2022 (€ 73,307) Unfavourable step	€ 108,089 Total debts 2024: € 108,089 ▼ 7% vs 2023 (€ 115,801) Favourable step	€ 81,140 Total debts 2025: € 81,140 ▼ 25% vs 2024 (€ 108,089) Favourable step	▼ 25%
Cash	€ 67,915 Cash 2022: € 67,915 First fiscal year in the series	€ 60,962 Cash 2023: € 60,962 ▼ 10% vs 2022 (€ 67,915) Unfavourable step	€ 82,585 Cash 2024: € 82,585 ▲ 35% vs 2023 (€ 60,962) Favourable step	€ 105,798 Cash 2025: € 105,798 ▲ 28% vs 2024 (€ 82,585) Favourable step	▲ 28%
Retained profit	€ 23,417 Retained profit 2022: € 23,417 First fiscal year in the series	€ 24,208 Retained profit 2023: € 24,208 ▲ 3% vs 2022 (€ 23,417) Favourable step	€ 28,777 Retained profit 2024: € 28,777 ▲ 19% vs 2023 (€ 24,208) Favourable step	€ 49,100 Retained profit 2025: € 49,100 ▲ 71% vs 2024 (€ 28,777) Favourable step	▲ 71%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 37,000 Dividend 2023: € 37,000 Unchanged (€ 0) Unchanged	€ 94,000 Dividend 2024: € 94,000 ▲ 154% vs 2023 (€ 37,000) Unchanged	€ 79,394 Dividend 2025: € 79,394 ▼ 16% vs 2024 (€ 94,000) Unchanged	▼ 16%
Bank debt	€ 60,950 Bank debt 2022: € 60,950 First fiscal year in the series	€ 57,997 Bank debt 2023: € 57,997 ▼ 5% vs 2022 (€ 60,950) Favourable step	€ 46,230 Bank debt 2024: € 46,230 ▼ 20% vs 2023 (€ 57,997) Favourable step	€ 44,382 Bank debt 2025: € 44,382 ▼ 4% vs 2024 (€ 46,230) Favourable step	▼ 4%
Balance sheet total	€ 115,324 Balance sheet total 2022: € 115,324 First fiscal year in the series	€ 158,609 Balance sheet total 2023: € 158,609 ▲ 38% vs 2022 (€ 115,324) Unchanged	€ 155,466 Balance sheet total 2024: € 155,466 ▼ 2% vs 2023 (€ 158,609) Unchanged	€ 148,840 Balance sheet total 2025: € 148,840 ▼ 4% vs 2024 (€ 155,466) Unchanged	▼ 4%

Key figures of J-C MAROT - médecine interne, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to J-C MAROT - médecine interne?

What happened at J-C MAROT - médecine interne in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 4, 2026 New annual accounts for financial year 2025: profit of € 99,718 (▲ 1% vs 2024). filed late Source: NBB ↗
2006 Jean Christophe MAROT became a director. NBB
Sep 25, 2006 New establishment in Namur. KBO
Sep 25, 2006 Start of the company according to the CBE. KBO

In short

From € 5,556 loss in 2022 to € 99,718 profit in 2025.

Paid € 93,098 in corporate taxes since 2022.

Best year ever: 2025, with € 99,718 profit.

Paid out € 210,394 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at J-C MAROT - médecine interne? We notify you, reason included.

Follow J-C MAROT - médecine interne

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Jean Christophe MAROT

J-C MAROT - médecine interne

Behind J-C MAROT - médecine interne is Jean Christophe MAROT.

See the full network in the app

Directors

According to the 2025 annual accounts

Jean Christophe MAROT

Manager

since 2006

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Marcel Lecomte(NR) 184

5000 Namur

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Cabinet dentaire LAST

€ 35,846 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0883.904.382
VAT number: BE 0883.904.382
Registered office: Rue Marcel Lecomte(NR) 184, 5000 Namur
Names & denominations: J-C MAROT - médecine interne
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 25 September 2006
Peppol: Active · Active since 23 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗